The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.

Corcept Therapeutics Incorporated

Veracyte, Inc.

Bruker Corporation

NeoGenomics, Inc.

Axsome Therapeutics, Inc.

Alkermes plc

Illumina, Inc.

Krystal Biotech, Inc.

Arrowhead Pharmaceuticals, Inc.

Neurocrine Biosciences, Inc.

Healthcare

First Trust NYSE Arca Biotechnology Index Fund

FBT Holdings & Sector Breakdown

FBT Holdings & Sector Breakdown